184 related articles for article (PubMed ID: 2886896)
21. Stress ulcers--prevention of gastrointestinal bleeding in critical care units.
Bank S
Med J Aust; 1985 Feb; 142 Spec No():S17-20. PubMed ID: 2869398
[No Abstract] [Full Text] [Related]
22. Implications of sucralfate-induced ulcer healing and relapse.
Lam SK
Am J Med; 1989 Jun; 86(6A):122-6. PubMed ID: 2660554
[TBL] [Abstract][Full Text] [Related]
23. [Pharmacological and therapeutic properties of lafutidine (stogar and protecadin), a novel histamine H2 receptor antagonist with gastroprotective activity].
Tanaka M; Banba M; Joko A; Moriyama Y
Nihon Yakurigaku Zasshi; 2001 Jun; 117(6):377-86. PubMed ID: 11436515
[TBL] [Abstract][Full Text] [Related]
24. Economic and health aspects of peptic ulcer disease and H2-receptor antagonists.
Jensen DM
Am J Med; 1986 Oct; 81(4B):42-8. PubMed ID: 2877574
[TBL] [Abstract][Full Text] [Related]
25. Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer disease.
Tytgat GN; Nio CY
Z Gastroenterol; 1987 Aug; 25 Suppl 3():152-61. PubMed ID: 3660894
[TBL] [Abstract][Full Text] [Related]
26. Does the choice of acute treatment influence future ulcer relapse?
Bodemar G
Scand J Gastroenterol Suppl; 1988; 155():141-51. PubMed ID: 3072664
[TBL] [Abstract][Full Text] [Related]
27. [Drug clinics. The drug of the month. Ranitidine bismuth citrate (Pylorid)].
Scheen AJ
Rev Med Liege; 1998 Jan; 53(1):41-4. PubMed ID: 9555183
[TBL] [Abstract][Full Text] [Related]
28. The pathophysiological and pharmacological basis of peptic ulcer therapy.
Freston JW
Toxicol Pathol; 1988; 16(2):260-6. PubMed ID: 2903542
[TBL] [Abstract][Full Text] [Related]
29. Role of protective drugs in the prevention of ulcer relapse.
Ota S; Terano A
J Gastroenterol; 1994 Jul; 29 Suppl 7():139-40. PubMed ID: 7921147
[TBL] [Abstract][Full Text] [Related]
30. Drugs for treatment of peptic ulcers.
Med Lett Drugs Ther; 1991 Nov; 33(858):111-4. PubMed ID: 1682791
[No Abstract] [Full Text] [Related]
31. Pharmacological management of patients with peptic ulcer disease: prospects for the late 1980's.
Thomson AB; Mahachai V
Clin Invest Med; 1987 May; 10(3):152-70. PubMed ID: 2887321
[TBL] [Abstract][Full Text] [Related]
32. Quality of healing in peptic ulcer disease--are H2 receptor antagonists all we need?
Korman MG
Gastroenterol Jpn; 1993 May; 28 Suppl 5():168-71. PubMed ID: 8103021
[TBL] [Abstract][Full Text] [Related]
33. Colloidal bismuth subcitrate in peptic ulcer--a review.
Tytgat GN
Digestion; 1987; 37 Suppl 2():31-41. PubMed ID: 3305117
[TBL] [Abstract][Full Text] [Related]
34. Ranitidine bismuth citrate-based triple therapy for seven days, with or without further anti-secretory therapy, is highly effective in patients with duodenal ulcer and Helicobacter pylori infection.
Marchi S; Costa F; Bellini M; Belcari C; Mumolo MG; Tornar A; Spisni R; Torelli E; Maltinti G
Eur J Gastroenterol Hepatol; 2001 May; 13(5):547-50. PubMed ID: 11396535
[TBL] [Abstract][Full Text] [Related]
35. Cytoprotective agents and ulcer relapse.
McLean AJ; McCarthy P; Dudley FJ
Med J Aust; 1985 Feb; 142(3):S25-8. PubMed ID: 3838199
[TBL] [Abstract][Full Text] [Related]
36. Treating peptic ulcer: an ongoing challenge.
Cohen MH
J Am Osteopath Assoc; 1995 Apr; 95(4):239-41. PubMed ID: 7744624
[No Abstract] [Full Text] [Related]
37. Problems associated with medical treatment of peptic ulcer disease.
Zimmerman TW
Am J Med; 1984 Nov; 77(5B):51-6. PubMed ID: 6095662
[TBL] [Abstract][Full Text] [Related]
38. The drug treatment of duodenal ulcer: physiological considerations in the choice of therapy.
Jones DB; Hunt RH
Aust N Z J Med; 1986 Apr; 16(2):263-7. PubMed ID: 2875708
[No Abstract] [Full Text] [Related]
39. Randomized comparison of ranitidine bismuth citrate-based triple therapies for Helicobacter pylori.
Laine L; Estrada R; Trujillo M; Emami S
Am J Gastroenterol; 1997 Dec; 92(12):2213-5. PubMed ID: 9399755
[TBL] [Abstract][Full Text] [Related]
40. Treatment of duodenal ulcer with sucralfate.
Lam SK
Scand J Gastroenterol Suppl; 1991; 185():22-8. PubMed ID: 1683491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
